What importance does radical prostatectomy have in lymph node-positive cancer of the prostate?;Welchen stellenwert hat die radikale prostatektomie beim lymphknotenpositiven prostatakarzinom?

Urologe - Ausgabe A

Volumn 37, Issue 2, 1998, Pages 138-140

  Huland, H ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Lymph node metastasis; Prostate cancer; Radical prostatectomy

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; HUMAN; LYMPH NODE METASTASIS; MALE; PELVIS LYMPH NODE; PROSTATE CANCER; PROSTATECTOMY;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0031943460     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050160     Document Type: Article

References (16)

1. Cheng CW, Bergstralh EJ, Zincke H (1993) Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy. Cancer 71: 996
2. Donohue RE, Mani JH, Whitesel JA, Augspurger RR, Williams G, Fauver HE (1990) Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma. Urology 35: 223
3. Petros JA, Catalona WJ (1992) Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 147: 1574
4. Danella JF, deKernion JB, Smith RB, Steckel J (1993) The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 149: 1488
5. Campbell SC, Klein EA, Levin HS, Piedmonte MR (1995) Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology 46: 352
6. Parra RO, Isorna S, Perez MG, Cummings JM, Boullier JA (1996) Radical perineal prostatectomy without pelvic lymphadenectomy: selection criteria and early results. J Urol 155: 612
7. Frazier HA, Robertson JE, Paulson DF (1994) Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J Urol 12: 308
8. Hanks GE, Krall JM, Pilepich MV, Asbell SO, Perez CA, Rubin P, Sause WT, Doggett RL (1992) Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification. Int J Radiat Oncol Biol Phys 23: 293
9. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC (1993) Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20: 713
10. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, Scardino PT (1989) Prognostic significance of lymph node metastases in prostate cancer. J Urol 142: 332
11. Catalona WJ, Smith DS (1994) 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152: 1837-1842
12. Walsh PC, Partin AW, Epstein JI (1994) Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152: 1831-1836
13. Abbas F, Scardino T (1993) Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. Urol Clin North Am 23: 587-604
14. Dillioglugil Ö, Leibman BD, Leibman NS, Kattan W, Rosas AL, Scardino PT (1997) Risk factors for complications and morbidity after radical retropubic prostatectomy. 157: 1760-1767
15. Aus G, Hugosson J, Norlen L (1995) Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. J Urol 154: 466-469
16. Conrad S, Graefen M, Pichlmeier U, Henke R-P, Hammerer PG, Huland H (in press) Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol